MESOTHELIOMA
Clinical trials for MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets genetic weakness in mesothelioma tumors
Disease control Not yet recruitingThis phase 2 trial tests a drug called BMS-986504 in 30 people with relapsed mesothelioma whose tumors have a specific genetic marker (MTAP deficiency). The drug aims to shrink tumors by blocking a protein cancer cells need to grow. Researchers will measure how many patients have…
Matched conditions: MESOTHELIOMA
Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New immune cocktail takes on deadly mesothelioma
Disease control Not yet recruitingThis phase 2 trial tests whether adding two immune-boosting drugs (iparomlimab and tovorilimab) to standard chemotherapy and bevacizumab can shrink tumors in people with advanced mesothelioma who have not had prior treatment. About 37 participants will receive the combination eve…
Matched conditions: MESOTHELIOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Experimental cell therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new cell therapy called KT032 in 24 adults with advanced solid tumors (ovarian, mesothelioma, colon cancer) that have spread to the abdomen and haven't responded to standard treatments. The main goal is to check safety and find the best dose, while …
Matched conditions: MESOTHELIOMA
Phase: EARLY_PHASE1 • Sponsor: Weijia Fang, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New breathing program aims to ease breathlessness in advanced lung cancer
Symptom relief Not yet recruitingThis study tests a short behavioral program called BREEZE+ to help people with advanced lung cancer manage breathlessness. The program includes three nurse-led sessions and a digital app that teaches breathing and relaxation skills. Researchers will compare this to usual care in …
Matched conditions: MESOTHELIOMA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC